wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47102176-225E341A-093C-4F29-8C21-074083F7FE64
Q47102176-225E341A-093C-4F29-8C21-074083F7FE64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47102176-225E341A-093C-4F29-8C21-074083F7FE64
The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy.
P2860
Q47102176-225E341A-093C-4F29-8C21-074083F7FE64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47102176-225E341A-093C-4F29-8C21-074083F7FE64
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2575002eb05657f6c2b6308433486b8f9479ba96
P2860
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].